Right Lobe Living Liver Transplants Regenerate Donors, Broaden Compatibility, Cut Immunosuppressive Burden

Living-Donor liver Transplants Offer Better Uptake And Lower Drug Burden, Transplant Teams Report

USA: Leading transplant surgeons and teams are highlighting advantages of living‑donor liver transplantation, saying the organ’s biology and surgical approaches can yield stronger graft uptake and a reduced need for long‑term immunosuppression. The discussion centers on the unique regenerative capacity of the liver and the careful matching required before any transplantation.

Clinicians describe a rigorous tissue‑matching process that focuses on blood group compatibility and evaluation of co‑morbidities, rather than relying solely on broad tissue typing. In select circumstances recipients and donors with complex infectious histories—including patients living with HIV—are now considered under carefully controlled protocols, reflecting evolving practice in transplantation medicine.

The technique commonly used in adult living‑donor procedures transfers the donor’s right lobe, which represents about 60% of the liver; both the donated portion and the donor’s remaining liver regenerate after surgery. Surgeons note that liver graft uptake tends to be more favorable than some other solid organs, and that many recipients require lower doses of post‑transplant immunosuppressive medication.

Transplant teams say outcomes can be striking: patients who were severely ill before transplantation often show rapid functional recovery and improved quality of life after surgery. As centers refine matching criteria and perioperative care, living‑donor liver transplantation is increasingly presented as a viable, life‑restoring option for those with advanced liver failure.

Video originally published on 2026-04-17 04:11:24